Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer

NCT00165854 is registered in ClinicalTrials.gov with Eisai Limited as lead sponsor.

NCT NCT00165854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00165854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer
Lead sponsor
Eisai Limited
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2003
Completion date
Not reported
Enrollment
46
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer (crc)